Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiency.
Blanco E. et al, (2025), J Exp Med, 222
Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements.
Griffen EJ. et al, (2024), Wellcome Open Res, 9
Turning high-throughput structural biology into predictive inhibitor design.
Saar KL. et al, (2023), Proc Natl Acad Sci U S A, 120